Entering text into the input field will update the search result below

Spatial Genomics And Transcriptomics Market Development And Business Intelligence

Mar. 04, 2021 5:24 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Major factors influencing the growth of the market.
  • Leading players & Business Strategies.
  • Geographic Overview.

Market growth influenced due to following factors-

  • Increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups.
  • Expanding applications in biomarker identification and drug discovery & development.
  • Increasing investment in biopharmaceutical R&D.

Global market size-

According to the new market research report Spatial Genomics Market is projected to reach $404 million by 2025, at a CAGR of 17.8% during the forecast period.  

Leading Players & Business Strategies -

The prominent players operating in the spatial genomics and transcriptomics market are 10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US).

NanoString Technologies Inc., held a dominant share in the global spatial genomics market. The company is engaged in the development, manufacturing, and commercialization of instruments, consumables, and services for profiling the activity of genes and proteins simultaneously from a single tissue sample. In 2019, the company launched the GeoMx Digital Spatial Profiler, enabling highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections. The company held a substantial market share in 2019 due to its brand presence and product offerings in the spatial genomics and transcriptomics market.

10X genomics held the second-largest position in the spatial genomics market in 2019. The company focuses on strengthening its market position by adopting organic and inorganic strategies, such as product launches and mergers & acquisitions. The company offers the Visium Spatial platform and consumables such as Visium Spatial Gene Expression assays and Visium mRNA arrays to measure spatial gene expression patterns using high-density DNA barcode sequencing arrays. The company acquired Spatial Transcriptomics (Sweden) in 2018 and entered the spatial genomics and transcriptomics market.  

For Details, Download PDF Brochure Here

Geographic Overview -

North America held the largest share in the global market, followed by Europe, with a share of 21.6%. The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics and transcriptomics market in this region.


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.